DIN 02472511 — NAT-TENOFOVIR 300 MG
NAT-TENOFOVIR is a tablet of Tenofovir Disoproxil Fumarate marketed by NATCO PHARMA (CANADA) INC. The full Tenofovir Disoproxil Fumarate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02472511
- Brand name
- NAT-TENOFOVIR
- Active ingredient
- Tenofovir Disoproxil Fumarate
- Strength
- 300 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NATCO PHARMA (CANADA) INC
- Health Canada status
- MARKETED
- Drug class
- Nucleotide analogue reverse transcriptase inhibitor (antiretroviral / antiviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tenofovir Disoproxil Fumarate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02516276 | AG-TENOFOVIR | 300 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02451980 | APO-TENOFOVIR | 300 MG | TABLET | APOTEX INC | MARKETED |
| 02460173 | AURO-TENOFOVIR | 300 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02479087 | JAMP-TENOFOVIR | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02512939 | MINT-TENOFOVIR | 300 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02452634 | MYLAN-TENOFOVIR DISOPROXIL | 300 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02453940 | PMS-TENOFOVIR | 300 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02515156 | RIVA-TENOFOVIR | 300 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |
| 02512327 | TENOFOVIR | 300 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02523922 | TENOFOVIR | 300 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02403889 | TEVA-TENOFOVIR | 300 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02247128 | VIREAD | 300 MG | TABLET | GILEAD SCIENCES CANADA INC | MARKETED |